Application of Bioactivity Profile-Based Fingerprints for Building Machine Learning Models
暂无分享,去创建一个
Lars Carlsson | Ola Engkvist | Günter Klambauer | Andreas Mayr | Yves Vandriessche | Noé Sturm | Hongming Chen | Jiangming Sun | L. Carlsson | G. Klambauer | Andreas Mayr | O. Engkvist | Hongming Chen | Noé Sturm | Jiangming Sun | Yves Vandriessche
[1] Hugo Ceulemans,et al. Large-scale comparison of machine learning methods for drug target prediction on ChEMBL , 2018, Chemical science.
[2] D A Scudiero,et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.
[3] Peter G. Schultz,et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.
[4] G. Maggiora,et al. Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.
[5] Nina Jeliazkova,et al. AMBIT RESTful web services: an implementation of the OpenTox application programming interface , 2011, J. Cheminformatics.
[6] Vijay S. Pande,et al. Massively Multitask Networks for Drug Discovery , 2015, ArXiv.
[7] Nina Jeliazkova,et al. Ambit‐Tautomer: An Open Source Tool for Tautomer Generation , 2013, Molecular informatics.
[8] Anne Mai Wassermann,et al. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes. , 2013, Journal of medicinal chemistry.
[9] Robert P. Sheridan,et al. Deep Neural Nets as a Method for Quantitative Structure-Activity Relationships , 2015, J. Chem. Inf. Model..
[10] Valerie J Gillet,et al. Effect of missing data on multitask prediction methods , 2018, Journal of Cheminformatics.
[11] Thomas Blaschke,et al. The rise of deep learning in drug discovery. , 2018, Drug discovery today.
[12] J N Weinstein,et al. Neural computing in cancer drug development: predicting mechanism of action. , 1992, Science.
[13] A. Bender,et al. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data. , 2016, ACS chemical biology.
[14] David M. Rocke,et al. Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.
[15] Jason Weston,et al. A unified architecture for natural language processing: deep neural networks with multitask learning , 2008, ICML '08.
[16] Brian K Shoichet,et al. A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.
[17] Peter S. Kutchukian,et al. Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput Screening. , 2017, ACS chemical biology.
[18] Álvaro Cortés Cabrera,et al. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm , 2018, J. Chem. Inf. Model..
[19] Andreas Verras,et al. Is Multitask Deep Learning Practical for Pharma? , 2017, J. Chem. Inf. Model..
[20] David M. W. Powers,et al. Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation , 2011, ArXiv.
[21] P. Petrone,et al. Aggregated Compound Biological Signatures Facilitate Phenotypic Drug Discovery and Target Elucidation. , 2016, ACS chemical biology.
[22] S. Hochreiter,et al. DeepTox: Toxicity prediction using deep learning , 2017 .
[23] A. Fliri,et al. Biospectra analysis: model proteome characterizations for linking molecular structure and biological response. , 2005, Journal of medicinal chemistry.
[24] A. Fliri,et al. Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.
[25] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[26] Lars Carlsson,et al. ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics , 2017, Journal of Cheminformatics.
[27] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[28] Andreas Bender,et al. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening , 2016, J. Chem. Inf. Model..
[29] Yuan Wang,et al. Using Information from Historical High-Throughput Screens to Predict Active Compounds , 2014, J. Chem. Inf. Model..
[30] Sebastian Ruder,et al. An Overview of Multi-Task Learning in Deep Neural Networks , 2017, ArXiv.
[31] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[32] Yanli Wang,et al. Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining , 2011, J. Chem. Inf. Model..
[33] Andy Liaw,et al. Demystifying Multitask Deep Neural Networks for Quantitative Structure-Activity Relationships , 2017, J. Chem. Inf. Model..
[34] J. Bajorath,et al. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. , 2010, Journal of medicinal chemistry.
[35] Nicole E. Bodycombe,et al. Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses , 2014, Journal of biomolecular screening.
[36] Knut Baumann,et al. Reliable estimation of prediction errors for QSAR models under model uncertainty using double cross-validation , 2014, Journal of Cheminformatics.
[37] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] Peter S. Kutchukian,et al. Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.
[39] Ron Artstein,et al. Survey Article: Inter-Coder Agreement for Computational Linguistics , 2008, CL.
[40] D. Bojanic,et al. Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.
[41] Anne Mai Wassermann,et al. A screening pattern recognition method finds new and divergent targets for drugs and natural products. , 2014, ACS chemical biology.
[42] Brian Kingsbury,et al. New types of deep neural network learning for speech recognition and related applications: an overview , 2013, 2013 IEEE International Conference on Acoustics, Speech and Signal Processing.
[43] Anne Mai Wassermann,et al. Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem's Bioassay Repository , 2016, J. Chem. Inf. Model..
[44] Anne Mai Wassermann,et al. Bioturbo Similarity Searching: Combining Chemical and Biological Similarity To Discover Structurally Diverse Bioactive Molecules , 2013, J. Chem. Inf. Model..